Seeking Alpha

Alexion gets a Breakthrough designation for ALXN1101

  • Alexion Pharma (ALXN) gets a Breakthrough Therapy designation for cyclic pyranopterin monophosphate for the treatment of MoCD. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector